Member Info for HelloSanDiego

Axe-Capital - "If Ukraine want to defend themselves in their own country against exactly this type of aggression then why shouldn't they?"

They should. Nobody suggested otherwise, so there was no need for that rant.

HPHQ - "This is/was Russia fault and Russia's alone"

It's pretty dumb blaming them entirely when their biggest fear was the threat of having missile silos just the other side of their border. We wouldn't put up with that so why should they?

Doc83 - "80% of phase 3 trials succeed. "

This says it's 58% - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226120/
This says it's 59% - https://academic.oup.com/biostatistics/article/20/2/273/4817524

But where Phase 3 is successful, they have an 80% chance of approval.

The thing that ticks me off is when you keep making stuff up and passing it off as a fact Wyndrum.

I'm going to hazard a guess someone just typed 108 instead of 180.

Shouldn't we have results by now?

Why?

If someone wanted to put £25m into the company today they'd still be paying 8p+ per share. With hindsight we know now they got a fair deal. But without the Ukraine situation pulling it down we'd still be comfortably above 7p, and for £25m worth you'd be paying 10p+. That's obvious to anyone who knows what they're talking about.

"Synairgen will continue to work on the SPRINTER study with Parexel Biotech... Day 35 data will be reported in the first instance followed by the long COVID results which will be collected until Day 90."

I think that's saying that PAREXEL will report the data to SYNAIRGEN in the first instance. I'm sure they'll want to announce all the results from a single trial in a single announcement, especially now we know they have all the data.

https://www.lse.co.uk/rns/SNG/synairgen-completes-phase-iii-recruitment-v0zt3dmd3zfxr8e.html

We're all agreed that Synairgen received the last of the 90-day follow-up data this week at the latest.

So does anyone still think they'll announce the results without including the 90-day outcome with it? Because I think that means we're looking at week-commencing 21st February for the results. Still leaves plenty of time for petty bickering before that, though.

Definitely looks like the price is being held back to fill a large order, in my opinion.

I wonder where the price wold be if the MMs hadn't repeatedly done that to secure Polygon's stake over the past few months.

SilveBackMerch - "Woodstock's point went straight over your head, as do most things it seems."

Still better than landing on it. That was my point.

Woodstock1970 - "If a nuclear war does happen, I would hope to be right underneath a bomb. "

I'd rather be a couple of thousand miles away. But each to their own.

Ndn71 - "macro economic risk you can do nothing about apart from take advantage - war? Buy arms manufacturers..."

You've just repeated Sceptik's point.

If war breaks out in Ukraine, investors will move a lot of their money to profit from the situation. It's reasonable to assume some of that money will move away from Synairgen.

BrucieJamieson - "I forecast the FTSE would go up 50 when Middle East war happened"

Well if we conquer Ukraine and find trillions of pounds worth of oil there, we're quids in.

The entire market fell noticeably a few weeks ago within minutes of the UK pulling some embassy staff out of Ukraine. Take a look at some share prices on January 24th.

It should be obvious that war would have a much greater effect.

WelshFalcon - "the tin hat brigade were ridiculed and largely ignored..."

Do you mean the people who claim there's a 'paid derampers' conspiracy? Because I prefer to try to reason with them and just point out the errors in their logic.

Manifesto - "Another paid muppet..I'd be asking for a refund....LOL!!"

I've been thinking about how many sales these paid derampers would have to generate to make it worthwhile.

50,000 shares a day would amount to 2.5% of Synairgen's volume on an average day. That's quite a lot. But if they timed it right I'd say they could knock 5 or 6% off the share price. They'd be competing with every other buyer out there though, so the people they're working for would only pick up half those excess shares at best. That means that for 25,000 shares they're investing £50k a day to make/save £1500 at the most, less 'staffing' costs. And with the obvious risks already there, it's likely to be less than that most days.

So what are the chances that investors on this board could be tricked into selling 50,000 shares a day between them, a couple of times a week, based on the opinions of some random posters on here?

Going by that page it looks like the Activ-2 study of SNG001 is expected to end Q2 2022. But the overall Activ-2 trial has an estimated completion date of December 2023. Here are links to the US government's official clinical trials register. They're worth keeping an eye on and get updated quite often.

Activ-2: https://clinicaltrials.gov/ct2/show/NCT04518410
Synairgen: https://clinicaltrials.gov/ct2/show/NCT04732949

Patagucci
It means it was developed for something else, but is seen as having the potential to treat covid. It's a common thing in drug development to look at other uses for existing drugs.

theboyg - "My uncle bought substantial amount of apple shares at $94 or so in 1989 ish"

The first company I invested in was GW Pharmaceuticals at £1 a share some time around 2010. I sold a them few months later. They moved from AIM to Nasdaq a few years after that and went private for over $200 a share in May last year.